BCBHF yields 71124681.52% · JNJ yields 2.14%● Live data
📍 BCBHF pulled ahead of the other in Year 1
Combined, BCBHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCBHF + JNJ for your $10,000?
Caribbean Investment Holdings Limited, through its subsidiaries, provides various banking, financial, and related services to individual and corporate customers primarily in Belize. The company offers lending, savings and merchant accounts, term deposits, and non-interest bearing and interest-bearing checking accounts; and credit and debit cards, as well as payment processing services to merchants. It also provides credit facilities that include overdrafts, lines of credit, and secured mortgage loans for personal, residential, or commercial purposes; and financial instruments, including commitments to extend credit, standby letters of credit, and financial guarantees. In addition, the company offers corporate services for its clients, such as virtual office, bookkeeping, and shipping agent services, as well as company formation and administration services. It operates a network of eleven branches and 28 ATMs, as well as 1,200 point of sale terminals. The company was formerly known as BCB Holdings Limited and changed its name to Caribbean Investment Holdings Limited in December 2015. Caribbean Investment Holdings Limited is headquartered in Providenciales, Turks and Caicos.
Full BCBHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.